Scotland’s farmers are ready to revive hemp, but Westminster says no. This feature exposes how outdated UK drug laws cripple sustainable agriculture and block economic opportunity. From ruined leaves to crushed profits, it’s a bureaucratic war on a zero-high crop. Farmers, researchers, and rebels are pushing back with seed, science, and stubbornness.
Reefer Report Card: The Week in Weed, Rated Vol. 21 — October 25 to November 1, 2025
This week, the global cannabis movement faced storms, setbacks, and scattered progress. Jamaica’s farmers reeled from Hurricane Melissa, U.S. politicians revived outdated fears about senior stoners, and Florida tangled its medical system in red tape. South Africa finally legalized personal use, while Congress kept banking reform buried. A chaotic week graded
Jamaica, Ganja, and the Eye of the Storm
Jamaica cannabis law, Dangerous Drugs Amendment 2015, Rastafari sacrament, Cannabis Licensing Authority, Hurricane Melissa, Jamaica Red Cross, Food For The Poor, UNICEF Jamaica, Direct Relief, GlobalGiving, Tourism economy, Crop loss, Climate resilience, Caribbean storms, Medical cannabis Jamaica
Singapore Still Hangs for Cannabis
Singapore still executes people for cannabis under its decades-old Misuse of Drugs Act. Officials call it deterrence. Critics call it fear. With public approval topping 90 percent, reformers face a government that equates mercy with weakness. This is a nation that kills for control and calls it safety.
Reefer Report Card: The Week in Weed, Rated October 25, 2025 – Vol. 20
Ohio rewrites its legalization law before it even starts, Wisconsin offers fake reform, and Massachusetts keeps spinning its regulatory wheels. The FDA pretends to act on CBD while the European Union adds new walls around its market. Reefer Report Card Vol. 20 grades another week of confusion, contradiction, and missed opportunities in global cannabis reform.
The Corporate Cure for Cannabis
A German biotech is pushing a cannabis pill called VER 01 and calling it a breakthrough for pain relief. Beneath the pharmaceutical polish is a deeper story about control, money, and culture. Pot Culture Magazine asks if Vertanical’s lab born weed is progress or just another corporate grab for the plant the people built.